These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29937354)

  • 1. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.
    Pavlyukov MS; Yu H; Bastola S; Minata M; Shender VO; Lee Y; Zhang S; Wang J; Komarova S; Wang J; Yamaguchi S; Alsheikh HA; Shi J; Chen D; Mohyeldin A; Kim SH; Shin YJ; Anufrieva K; Evtushenko EG; Antipova NV; Arapidi GP; Govorun V; Pestov NB; Shakhparonov MI; Lee LJ; Nam DH; Nakano I
    Cancer Cell; 2018 Jul; 34(1):119-135.e10. PubMed ID: 29937354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
    Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
    Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
    Nakano I; Garnier D; Minata M; Rak J
    Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of WISP1 as a novel oncogene in glioblastoma.
    Jing D; Zhang Q; Yu H; Zhao Y; Shen L
    Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
    Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
    Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
    Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
    Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
    Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
    Front Immunol; 2019; 10():3137. PubMed ID: 32038644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.
    Pötschke R; Gielen G; Pietsch T; Kramm C; Klusmann JH; Hüttelmaier S; Kühnöl CD
    Pediatr Res; 2020 Mar; 87(4):669-676. PubMed ID: 31756732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.
    Simon T; Pinioti S; Schellenberger P; Rajeeve V; Wendler F; Cutillas PR; King A; Stebbing J; Giamas G
    Mol Cancer; 2018 Aug; 17(1):132. PubMed ID: 30165850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.
    Bronisz A; Wang Y; Nowicki MO; Peruzzi P; Ansari K; Ogawa D; Balaj L; De Rienzo G; Mineo M; Nakano I; Ostrowski MC; Hochberg F; Weissleder R; Lawler SE; Chiocca EA; Godlewski J
    Cancer Res; 2014 Feb; 74(3):738-750. PubMed ID: 24310399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
    Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
    J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.
    Li Y; Wang X; Qi S; Gao L; Huang G; Ren Z; Li K; Peng Y; Yi G; Guo J; Yang R; Wang H; Zhang X; Liu Y
    Neuro Oncol; 2021 Oct; 23(10):1693-1708. PubMed ID: 34042961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma hijacks microglial gene expression to support tumor growth.
    Maas SLN; Abels ER; Van De Haar LL; Zhang X; Morsett L; Sil S; Guedes J; Sen P; Prabhakar S; Hickman SE; Lai CP; Ting DT; Breakefield XO; Broekman MLD; El Khoury J
    J Neuroinflammation; 2020 Apr; 17(1):120. PubMed ID: 32299465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.